[1]
Alizai, H.N.K., Pasha, A., Alizai, P.K. and Zia, N. 2025. The first approved drug for abnormal bone formation: palovarotene challenges and way forward. Journal of the Pakistan Medical Association. 74, 06 (Jun. 2025), 940–942. DOI:https://doi.org/10.47391/JPMA.10894.